Publications by authors named "D Ternant"

Claim this Profile
C
Cerebral diffusion of posaconazole in an experimental model of disseminated scedosporiosis.
Bénédicte Lelièvre, Charlotte Godon, Pierre Legras, Jérémie Riou, David Ternant

Biomed Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics.
David Ternant, Olivier Le Tilly, Guillaume Cartron, Céline Desvignes, Amina Bensalem

Clin Pharmacokinet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update.
James Bluett, Merita Rumano, María José Martínez Becerra, Floris Loeff, Mehmet Itik, David Ternant

Basic Clin Pharmacol Toxicol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients.
Blaise Pasquiers, Benoit Blanchet, Xavier Puéchal, Xavier Declèves, Pascal Cohen, David Ternant

EBioMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data.
Héloïse Bourien, Xavier Adhoute, Boris Campillo-Gimenez, Mohamed Bouattour, Eric Assenat, David Ternant

Dig Liver Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis